Indium 111 ABT 806Alternative Names: 111In-ABT-806; ABT-806i
Latest Information Update: 16 Jul 2016
At a glance
- Originator Abbott Laboratories
- Class Antineoplastics; Radiopharmaceutical diagnostics
- Mechanism of Action Epidermal growth factor receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Solid-tumours(Diagnosis) in Australia (IV, Infusion)
- 31 Oct 2011 Phase-I clinical trials in Solid tumours in Australia (IV)